Novo Nordisk

Congress senate house government US
Pharma

Novo CEO agrees to discuss potential GLP-1 price cuts with PBMs

At the Senate committee hearing on Novo Nordisk's Ozempic and Wegovy prices, insurance-related debate took up much of the conversation.
Zoey Becker Sep 24, 2024 5:03pm
Novo Nordisk

Novo readies its defense for Senate drug pricing hearing

Sep 24, 2024 9:32am
The Capitol Building in Washington DC with bright blue sky - stock photo Becky WrightGetty Images

Lawmakers urge government to allow generics to Novo GLP-1s

Sep 23, 2024 5:28pm
Lilly Raheen Ireland

Lilly reveals $1.8B in investments at Irish manufacturing sites

Sep 12, 2024 5:30am
obesity overweight weight loss weigh

Big Pharmas back OAC’s ‘Your Weight Matters’ campaign challenge

Sep 10, 2024 11:04am
Breakthroughs

Breakthroughs Honorees

Sep 9, 2024 5:01am